See every side of every news story
Published loading...Updated

Inside NVIDIA and ConcertAI's partnership to build AI agents for oncology trials

Summary by Drug Discovery and Development
In 2025, AI “agents” are a growing trend—from coding applications like Claude Code to content retrieval tools like OpenAI’s DeepResearch. But while many organizations are merely wading into these new waters, ConcertAI is diving headfirst alongside NVIDIA. By pairing clinical-grade, multi-modal oncology data with an integrated network of specialized AI “agents” (including a blend of… The post Inside NVIDIA and ConcertAI’s alliance to build AI age…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Discovery and Development broke the news in on Friday, March 21, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.